Seminars in Radiation Oncology

Papers
(The median citation count of Seminars in Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Spatially Fractionated Radiotherapy in the Era of Immunotherapy52
Global Workforce and Access: Demand, Education, Quality51
The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies41
The Quality Assurance of a 1.5 T MR-Linac30
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets27
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician27
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer25
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management25
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology24
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription23
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy23
The Role of Radiation Therapy for Palliation of Hematologic Malignancies23
Integrating the Patient's Voice in Toxicity Reporting and Treatment Decisions for Breast Radiotherapy22
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma21
Artificial Intelligence for Outcome Modeling in Radiotherapy19
The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future18
Introduction: Personalization of Cancer Care for Older Adults18
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm17
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology17
Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control17
Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon16
Novel Survivorship Paradigms in Head/Neck Cancer14
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas14
Intrafraction Motion Management With MR-Guided Radiation Therapy14
Uncertainty Assessment for Deep Learning Radiotherapy Applications13
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation Resistance12
Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions12
De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions12
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer11
Optimizing Informed Consent in Cancer Clinical Trials11
The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization11
Mature Experiences Using Local Therapy for Oligometastases10
Advances in Automated Treatment Planning10
Technical Giants But Biologic Infants: Defining a More Sophisticated Role for Local Therapy in Metastatic Disease10
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy10
Biology of HPV Mediated Carcinogenesis and Tumor Progression10
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity9
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology9
Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy9
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management9
The Role of Radiotherapy in Hematologic Malignancies in Children, Adolescents, and Young Adults9
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck9
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations8
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers8
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?8
Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast8
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer8
Green Horizons in Oncology: A Blueprint for Environmentally Sustainable Radiation Therapy Facilities7
Democratizing FLASH Radiotherapy7
Introduction: Radiation Therapy in Oligometastatic Disease7
Hypofractionation in Older Adults With Glioblastoma7
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care7
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer Models7
Theranostics and Patient-Specific Dosimetry6
Radiotherapy Dose in Patients Receiving Immunotherapy6
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications6
Advancing Towards Personalized Prescription of Radiotherapy Dose6
The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity6
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions6
Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice6
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance6
The History and Future of Multidisciplinary Cancer Care6
Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer6
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer5
Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC)5
Radiation-Therapy Related Salivary Dysfunction5
Integration of Radiation and Reconstruction After Mastectomy5
Prevention and Screening of HPV Malignancies5
De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches5
Modern Treatment Delivery of Radiotherapy for Lymphomas and Leukemias: Making Every Gy Count5
Chromosome Missegregation as a Modulator of Radiation Sensitivity5
MRI-Guided Adaptive Radiation Therapy5
Managing Patients with Head and Neck Cancer and Advanced Age or Comorbidities5
Hypoxia-Targeted Dose Painting in Radiotherapy5
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation5
MRgRT Quality Assurance for a Low-Field MR-Linac4
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status4
Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-834
Radiation Therapy in the Management of Adrenal Metastases4
Oncometabolites as Regulators of DNA Damage Response and Repair4
The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy4
The Future of Education in Radiation Oncology4
The Use of MR-Guided Radiation Therapy for Liver Cancer4
Mechanisms of Immune Modulation by Radiation4
The Spectrum of Metastasis: An Opportunity for Cure?4
Future of Multidisciplinary Team in the Context of Adaptive Therapy4
The Biological Process of Aging and the Impact of Ionizing Radiation4
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations3
Oral Mucositis in Head and Neck Cancer Patients3
Standardization of Artificial Intelligence Development in Radiotherapy3
Prognostic and Predictive Clinical and Biological Factors in HPV Malignancies3
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing3
Editorial3
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy3
Quality Assurance for AI-Based Applications in Radiation Therapy3
Advancing the Collaboration Between Imaging and Radiation Oncology3
Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas3
A Partial Tumor Irradiation Approach for Complex Bulky Disease3
The Future of Safety and Quality in Radiation Oncology3
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?3
The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal3
Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?3
Artificial Intelligence for Image Registration in Radiation Oncology3
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas3
0.086667060852051